The potential application of SKA1-3 for the development and pathogenesis of HCC, as well as the related oncogenic signaling pathways were analyzed in our present study to develop multi-targeted and SKA1–3-targeted therapies. The gene discussed is SKA1; the disease is hepatocellular carcinoma.